Drug-Drug Interaction between Psychiatric Medications and Experimental Treatments for Coronavirus Disease-19: A Mini-Review | Zendy

Hananeh Baradaran | Zendy; Nazanin Gorgzadeh | Zendy; Houman Seraj | Zendy; Anahita Asadi | Zendy; Danial Shamshirian | Zendy; Maryam Rezapour | Zendy

Open Access

Drug-Drug Interaction between Psychiatric Medications and Experimental Treatments for Coronavirus Disease-19: A Mini-Review

Author(s) -

Hananeh Baradaran,

Nazanin Gorgzadeh,

Houman Seraj,

Anahita Asadi,

Danial Shamshirian,

Maryam Rezapour

Publication year - 2020

Publication title -

open access macedonian journal of medical sciences

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.288

H-Index - 17

ISSN - 1857-9655

DOI - 10.3889/oamjms.2020.5010

Subject(s) - medicine , lopinavir , psychiatry , atazanavir , ritonavir , pandemic , drug , hydroxychloroquine , mental illness , disease , intensive care medicine , mood , covid-19 , coronavirus , recreational drug , mood disorders , pharmacology , mental health , anxiety , infectious disease (medical specialty) , human immunodeficiency virus (hiv) , virology , antiretroviral therapy , viral load

The pandemic of coronavirus disease (COVID)-2019 has been affected many people all around the world. Patients with mental disorders are not as safe as others; also, they might be more vulnerable in such situations. These patients take various medications, which can lead to numerous drug-drug interactions with experimental drugs uses against COVID-19. According to the potential critical interactions, we reviewed the reputable databases to find the interactions between main categories of psychiatric medications (e.g., antidepressants, anti-psychotics, sedative/hypnotics, and mood stabilizers) when used in concomitant with COVID-19 experimental agents (e.g., hydroxychloroquine, lopinavir/ritonavir, atazanavir, and chloroquine). We hope the list provided in this review helps the clinical care staff in treating patients with mental illness infected with severe acute respiratory syndrome coronavirus 2 during the COVID-19 pandemic.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research